The Effect of Rivaroxaban in Sickle Cell Disease
Clinical trial NCT02072668 · COMPLETED
Trial details
- NCT number
- NCT02072668
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2018-10-04
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.